ESR1 and breast cancer: Oncologists define luminal A as estrogen receptor (ER) > 1%, progesterone receptor (PR) ≥ 20%, breast cancer with negative human epidermal growth factor receptor-2 (HER2), and Ki-67 < 14% of clinical cases [4].